These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 28460113
1. Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey. Rossignol P, Lamiral Z, Frimat L, Girerd N, Duarte K, Ferreira J, Chanliau J, Castin N. Nephrol Dial Transplant; 2017 Dec 01; 32(12):2112-2118. PubMed ID: 28460113 [Abstract] [Full Text] [Related]
2. Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K). Ni Z, Jin H, Lu R, Zhang L, Yao L, Shao G, Zuo L, Qin S, Zhang X, Zhang Q, Yu W, Luo Q, Ren Y, Peng H, Xiao J, Yang Q, Chen Q, Shi Y, PRECEDE-K study group. BMC Nephrol; 2023 Aug 09; 24(1):233. PubMed ID: 37559023 [Abstract] [Full Text] [Related]
6. Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K). Jin H, Lu R, Zhang L, Yao L, Shao G, Zuo L, Qin S, Zhang X, Zhang Q, Yu W, Luo Q, Ren Y, Peng H, Xiao J, Yang Q, Chen Q, Shi Y, Ni Z. Ren Fail; 2024 Dec 09; 46(2):2384585. PubMed ID: 39252179 [Abstract] [Full Text] [Related]
7. Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study. Fishbane S, Jadoul M, Dember L, Kovesdy CP, Al-Shurbaji A, Lisovskaja V, Sekar P, Katona B, Guzman N, Herzog C. BMJ Open; 2023 May 25; 13(5):e071309. PubMed ID: 37230521 [Abstract] [Full Text] [Related]
10. Prescription patterns of dialysate potassium and potassium binders and survival on haemodialysis-the French Renal Epidemiology and Information Network registry. Mercadal L, Lambert O, Couchoud C, Metzger M, Edet S, Merle S, Jacquelinet C, Stengel B. Nephrol Dial Transplant; 2021 Jan 01; 36(1):151-159. PubMed ID: 32582941 [Abstract] [Full Text] [Related]
13. Adverse gastrointestinal events with sodium polystyrene sulphonate and calcium polystyrene sulphonate use in dialysis patients: a nationwide registry study. Ferreira JP, Couchoud C, Edet S, Brunet P, Frimat L. Nephrol Dial Transplant; 2021 Jan 25; 36(2):339-345. PubMed ID: 33247730 [Abstract] [Full Text] [Related]
14. The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia. Haas JS, Krinke KS, Maas C, Hardt T, Barck I, Braun S. BMC Nephrol; 2020 Aug 08; 21(1):332. PubMed ID: 32770956 [Abstract] [Full Text] [Related]
19. Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis. Tsiagka D, Georgianos PI, Pikilidou MI, Vaios V, Roumeliotis S, Syrganis C, Mavromatidis K, Metallidis S, Liakopoulos V, Zebekakis PE. Int Urol Nephrol; 2022 Sep 08; 54(9):2327-2334. PubMed ID: 35133576 [Abstract] [Full Text] [Related]
20. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease. Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE. Int Urol Nephrol; 2017 Dec 08; 49(12):2217-2221. PubMed ID: 29027620 [Abstract] [Full Text] [Related] Page: [Next] [New Search]